Investor Relations · Technologies
The technology platforms behind the Group
Four in-house technology platforms power every Novogenia product and brand: an accredited genetic and blood laboratory, personalized supplementation, personalized cosmetics, and the AI engines that interpret genetic data at scale.
Our four technology platforms
High-throughput analysis of the human genome and metabolome in our accredited laboratories.
- One sample, many analyses: DNA, blood, biochemical, virological and diagnostic testing under accredited quality systems.
- Proven at scale as one of the leading SARS-CoV-2 PCR laboratories during the pandemic.
- The only laboratory in Austria licensed to analyse embryos (preimplantation genetic testing).
Our accredited, high-throughput genetic and blood laboratory in Salzburg decodes the human genome and metabolome at scale. From a single sample we run DNA analysis alongside biochemical, virological and diagnostic testing under accredited quality systems — the analytical foundation for every personalized product and therapy in the Group.
The same facility scaled to become one of the leading SARS-CoV-2 PCR testing laboratories during the COVID-19 pandemic, proving the throughput and reliability of our platform under extreme demand. At the top of our range, Novogenia is the only laboratory in Austria licensed to perform genetic analysis on embryos (preimplantation genetic testing) — a uniquely regulated, high-end capability.
Our laboratories cover the entire spectrum of analytics — from lifestyle testing to highly regulated embryo diagnostics.
Supplements formulated for each customer from their own lab-analysis data.
- Each formula calculated from the customer’s own genetic and lab data, not one-size-fits-all pills.
- Made in house end to end: formulation, dosing, mixing, filling and packaging.
- Reformulated whenever new analysis data arrives, closing the analyse-to-product loop.
Each supplement is formulated individually from the customer’s own genetic and lab-analysis data and produced in house — the right nutrients, in the right dose, matched to that person’s biology. Rather than selling one-size-fits-all pills, we calculate each person’s requirement for vitamins, minerals, amino acids and other micronutrients from their genetic profile and lifestyle, then manufacture a tailored daily formulation.
Production runs end to end under our own roof — from formulation and dosing to mixing, filling and packaging — so quality and personalization are controlled at every step.
Cosmetics personalized from genetic and skin-analysis data.
- Skincare matched to each person’s skin biology from genetic and skin-analysis data.
- Actives and concentrations chosen for markers like collagen breakdown, oxidative stress and moisture retention.
- Produced on our own manufacturing lines as a fully integrated value chain.
Skincare is personalized from genetic and skin-analysis data and manufactured in house, so each formulation targets the individual’s specific skin biology rather than a one-size-fits-all product. Genetic markers for factors such as collagen breakdown, oxidative stress, moisture retention and skin sensitivity guide which active ingredients — and which concentrations — are blended into each customer’s product.
Like our supplements, the cosmetics are produced on our own manufacturing lines, giving the Group another fully integrated, in-house value chain from analysis to finished, individualized formulation.
AI engines that interpret genetic data and millions of scientific publications.
- Interprets genetic data against millions of scientific publications.
- Turns raw lab results into clear, personalized recommendations.
- Drives the analyse → product → re-analyse feedback loop across the Group.
Our AI engines interpret genetic data against millions of scientific publications, identifying the traits and relationships that turn raw lab data into actionable insight. The same models continuously improve our reports, detect inefficiencies in therapies, and power the “analyse → product → re-analyse” feedback loop at the heart of the Group.
Investor & press contact
Questions from shareholders, analysts or media? Our Investor Relations team is happy to help.